News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Cartesian Therapeutics
NEWS
JOBS
IN THE PRESS
NEWS
Deals
Selecta’s IPO Expected Next Week; Sixth Biotech in Massachusetts to Go Public This Year
June 20, 2016
·
2 min read
Business
Sanofi Adds Celiac Disease to the Menu With $300 Million Selecta Bet
May 13, 2015
·
2 min read
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Press Releases
Cartesian Therapeutics Announces FDA Special Protocol Assessment Agreement for Phase 3 AURORA Trial of Descartes-08 in Myasthenia Gravis
January 27, 2025
·
7 min read
Press Releases
Cartesian Therapeutics Highlights Progress and 2025 Strategic Priorities Across Pipeline of mRNA Cell Therapies for Autoimmune Diseases
January 14, 2025
·
8 min read
Press Releases
Cartesian Therapeutics Announces New Employment Inducement Grants - January 7, 2025
January 8, 2025
·
1 min read
Press Releases
Cartesian Therapeutics Announces New Employment Inducement Grants - December 18, 2024
December 19, 2024
·
1 min read
Press Releases
Cartesian Therapeutics Announces Positive Updated Results from Phase 2b Trial of Descartes-08 in Participants with Myasthenia Gravis and Outlines Design of Planned Phase 3 Trial
December 3, 2024
·
12 min read
Press Releases
Cartesian Therapeutics to Present Updated Data from Phase 2b Trial of Descartes-08 in Patients with Myasthenia Gravis at the 2nd Annual Cell Therapy for Autoimmune Disease Summit
November 21, 2024
·
6 min read
Press Releases
Cartesian Therapeutics Announces New Employment Inducement Grants - November 8, 2024
November 11, 2024
·
1 min read
Press Releases
Cartesian Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
November 7, 2024
·
17 min read
Press Releases
Cartesian Therapeutics Announces Presentation at the Upcoming 66th ASH Annual Meeting
November 5, 2024
·
2 min read
Press Releases
Cartesian Therapeutics Announces Presentation of Results from Phase 2b Trial of Descartes-08 in Patients with Myasthenia Gravis at the 2024 MGFA Scientific Session of the AANEM Annual Meeting
October 15, 2024
·
8 min read
